(1S,2S)-2-(Diphenylphosphino)-2,3-dihydro-1H-inden-1-amine, 95.0%, 1g

Cacothéline, >=95%, pa, 1 g, emballage en verre

FURSULTIAMINE, 95%, 100mg

(3-Methylbutan-2-yl)hydrazine dihydrochloride, 95%, 500mg

Furo[2,3-d]pyrimidin-4-amine, 95.0%, 5g

tert-Butyl 2-bromo-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate, 95.0%, 250mg

Benzyl (5-bromopyridin-2-yl)carbamate, 95.0%, 1g

1,3,5-Tris[4-(9-carbazolyl)phenyl]benzene>98.0%(HPLC)(N)1g

Fmoc-(S)-3-Amino-4-(4-bromo-phenyl)-butyric acid, 97%, 250mg

(ethylsulfonyl)acetic acid, 95.0%, 1g

N-BOC-N-(2-CYANOETHY)GLYCINE, 95.0%, 250mg

Methyl 5-fluoro-2-methylnicotinate, 97%, 1g

(4-(Trifluoromethyl)thiazol-2-yl)methanol, 95.0%, 100mg